- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 215/38 - Nitrogen atoms
Patent holdings for IPC class C07D 215/38
Total number of patents in this class: 961
10-year publication summary
|
47
|
53
|
50
|
54
|
39
|
46
|
59
|
39
|
33
|
7
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 9632 |
35 |
| Institut Curie | 531 |
32 |
| Abivax | 105 |
30 |
| Aldeyra Therapeutics, Inc. | 100 |
29 |
| Universite de Montpellier | 920 |
28 |
| Vertex Pharmaceuticals Incorporated | 1581 |
21 |
| Janssen Pharmaceutica N.V. | 3839 |
17 |
| Bristol-myers Squibb Company | 5080 |
12 |
| F. Hoffmann-La Roche AG | 7958 |
11 |
| Syngenta Participations AG | 4970 |
11 |
| Abbvie Inc. | 1808 |
11 |
| Boehringer Ingelheim International GmbH | 4629 |
10 |
| AstraZeneca AB | 3042 |
9 |
| Amgen Inc. | 3779 |
9 |
| Takeda Pharmaceutical Company Limited | 2961 |
9 |
| The Regents of the University of California | 18943 |
8 |
| Aerie Pharmaceuticals, Inc. | 131 |
8 |
| Merck Sharp & Dohme LLC | 3689 |
8 |
| Gilead Sciences, Inc. | 1879 |
7 |
| HMI Medical Innovations, LLC | 20 |
7 |
| Other owners | 649 |